Lj. Sun et al., ARGININE-VASOPRESSIN TRANSPORT AND METABOLISM IN THE PIGMENTED RABBITCONJUNCTIVA, European journal of pharmaceutical sciences, 6(1), 1998, pp. 47-52
The purpose of this study was to evaluate the transepithelial transpor
t and metabolism of arginine vasopressin (AVP) in the pigmented rabbit
conjunctiva, both in the absence and presence of protease inhibitors.
The apparent permeability coefficient, P-app, for H-3-AVP was determi
ned in the modified Ussing chamber, and AVP metabolites were monitored
by reversed phase HPLC using a C-18 column. At 50 nM donor H-3-AVP, t
he P-app in the mucosal-to-serosal (ms) direction was about five times
higher than that in the opposite direction. Excess (0.1 mM) AVP decre
ased the P-app for labelled AVP in the mucosal-to-serosal (ms) directi
on by about 50%. However, intact AVP transport showed neither concentr
ation nor direction dependence. HPLC analysis revealed two subspecies
of H-3-AVP in the receiver fluid and virtually no degradation products
in the donor fluid following 3 h flux experiments. H-3-AVP transporte
d in the ms direction underwent extensive hydrolysis (73%), which was
decreased by 33% with mucosal application of 2 mM camostat mesylate (a
n aminopeptidase inhibitor) or by 27% with 0.5 mM leupeptin (a serine
protease inhibitor). By contrast, H-3-AVP transported in the serosal-t
o-mucosal (sm) direction resulted in only 37% hydrolysis, and mucosal
application of either inhibitor did not significantly affect the P-app
for intact AVP. These data suggest that intact AVP transport in the c
onjunctiva may be mediated mostly by passive diffusion and enzymatic d
egradation of AVP may be mediated by proteolytic enzymes present on th
e mucosal side of the conjunctiva. (C) 1998 Elsevier Science B.V.